Nextage Therapeutics Ltd (TLV:NXTG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
41.60
+2.60 (6.67%)
Jul 24, 2026, 1:24 PM IDT

Nextage Therapeutics Financials Overview

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.240.410.88-0.090.19
Revenue Growth
-41.16%-52.85%---52.36%-
Gross Profit
0.130.080.23-0.020.13
Operating Income
-3.19-3.44-3.99-5.85-7.12-6.4
Net Income
2.84-3.28-3.88-5.59-7.73-15.97
Earnings Per Share
0.16-0.10-0.13-0.20-0.30-1.40
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.170.250.481.13-2.07
Total Debt
12.610.210.380.33-0.84
Net Cash (Debt)
-12.440.040.10.8-1.23
Net Cash Growth
--57.43%-87.30%---
Net Cash Per Share
-0.700.000.000.03-0.11

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-2.32-0.8-2.26-6.01-3.97-6.31
Capital Expenditures
----0--0.01
Free Cash Flow
-2.32-0.8-2.26-6.02-3.97-6.32
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
51.85%18.40%25.69%-17.58%69.63%
Operating Margin
-1310.70%-832.69%-455.14%--7825.28%-3348.69%
Pretax Margin
1004.12%-840.19%-479.79%--8717.58%-8359.16%
Profit Margin
1169.14%-794.92%-442.81%--8492.31%-8359.16%
FCF Margin
-954.73%-192.49%-258.22%--4367.03%-3309.42%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
54.0857.53----